APA

Sato Y., Bando H., Di Piazza M., Gowing G., Herberts C., Jackman S., Leoni G., Libertini S., MacLachlan T., McBlane J. W., Pereira Mouriès L., Sharpe M., Shingleton W., Surmacz-Cordle B., Yamamoto K. & van der Laan J. W. (20200605). Tumorigenicity assessment of cell therapy products: The need for global consensus and points to consider. : Cytotherapy.

Chicago

Sato Y, Bando H, Di Piazza M, Gowing G, Herberts C, Jackman S, Leoni G, Libertini S, MacLachlan T, McBlane J W, Pereira Mouriès L, Sharpe M, Shingleton W, Surmacz-Cordle B, Yamamoto K and van der Laan J W. 20200605. Tumorigenicity assessment of cell therapy products: The need for global consensus and points to consider. : Cytotherapy.

Harvard

Sato Y., Bando H., Di Piazza M., Gowing G., Herberts C., Jackman S., Leoni G., Libertini S., MacLachlan T., McBlane J. W., Pereira Mouriès L., Sharpe M., Shingleton W., Surmacz-Cordle B., Yamamoto K. and van der Laan J. W. (20200605). Tumorigenicity assessment of cell therapy products: The need for global consensus and points to consider. : Cytotherapy.

MLA

Sato Y, Bando H, Di Piazza M, Gowing G, Herberts C, Jackman S, Leoni G, Libertini S, MacLachlan T, McBlane J W, Pereira Mouriès L, Sharpe M, Shingleton W, Surmacz-Cordle B, Yamamoto K and van der Laan J W. Tumorigenicity assessment of cell therapy products: The need for global consensus and points to consider. : Cytotherapy. 20200605.